CIBC Private Wealth Group
XFOR icon

CIBC Private Wealth Group’s X4 Pharmaceuticals XFOR Stock Holding History

CIBC Private Wealth Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.66K Hold
2,166
– – ﹤0.01% 2467
2025
Q3 		$7.41K Hold
2,166
– – ﹤0.01% 2480
2025
Q2 		$4.12K Hold
2,166
– – ﹤0.01% 2495
2025
Q1 		$13.8K Buy
+2,166
New +$29.8K ﹤0.01% 2132
2024
Q4 		– Sell
-1,500
Closed -$30.1K – 3213
2024
Q3 		$30.1K Hold
1,500
– – ﹤0.01% 1973
2024
Q2 		$26.2K Hold
1,500
– – ﹤0.01% 1937
2024
Q1 		$63.5K Hold
1,500
– – ﹤0.01% 1571
2023
Q4 		$37.7K Hold
1,500
– – ﹤0.01% 1113
2023
Q3 		$49K Hold
1,500
– – ﹤0.01% 1050
2023
Q2 		$87.3K Buy
1,500
+117
+8% +$6.01K ﹤0.01% 856
2023
Q1 		$36.1K Buy
+1,383
New +$40.5K ﹤0.01% 868

Other funds holding XFOR

EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

CIBC Private Wealth Group's XFOR Position: Q4 2025 in Review

CIBC Private Wealth Group held its X4 Pharmaceuticals (XFOR) position steady in Q4 2025 at 2,166 shares worth $8.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

CIBC Private Wealth Group first reported a position in XFOR in Q1 2023 and has held it in 11 quarters since. The position peaked at $87.3K in Q2 2023. 79 funds tracked by Wall St. Rank hold XFOR as of Q4 2025.

  • CIBC Private Wealth Group held 2,166 shares of X4 Pharmaceuticals worth $8.66K as of Q4 2025.
  • CIBC Private Wealth Group left its X4 Pharmaceuticals share count unchanged in Q4 2025.
  • X4 Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2467 holding.
  • CIBC Private Wealth Group first reported a position in X4 Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • CIBC Private Wealth Group's X4 Pharmaceuticals position peaked at $87.3K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.